CENTRUS ENERGY CORP

Company Overview

Centrus Energy (LEU) is a U.S. nuclear fuel supplier operating two segments: LEU sales (SWU and UF6) and Technical Solutions (enrichment, centrifuge manufacturing and DOE-funded HALEU work). The company reported a multi-year backlog (~$3.6–$3.7 billion) that extends to 2040 for LEU and is the only U.S. licensee actively enriching up to 20% U‑235, with HALEU production and milestone deliveries beginning in 2023 and a Phase 2 delivery of 900 kg in June 2025. Its model mixes commercial fixed‑term contracts, spot/inventory activity and cost‑plus government work, and management emphasizes dependence on DOE appropriations, export/waiver outcomes, and non‑Russian supply availability.

Executive Compensation Practices

Compensation is likely tied to long‑dated, programmatic performance rather than short‑term spot metrics given the long tenors of LEU contracts and large backlog; relevant performance metrics will include backlog growth/contract awards, HALEU production volumes and successful centrifuge deployment (Oak Ridge), margin improvement, safety/compliance and execution of DOE task orders. The company’s recent disclosures show material drivers of profitability (SWU/UF6 market prices, contract mix, and cost pressures from inventory purchases) and volatility from pension remeasurements and deferred tax items — all of which can cause realized pay outcomes (bonuses, equity vesting) to diverge from GAAP revenue trends. Stock‑based compensation is explicitly noted in recent quarters and, combined with the 2024 convertible note issuance and ATM activity, suggests pay packages likely include equity and option grants to retain technical talent and align management with long‑term capital and dilution considerations.

Insider Trading Considerations

Insider trading patterns at Centrus will be particularly sensitive to nonpublic information about DOE awards, appropriations, waiver outcomes (Import Ban Act/Russian Decree), HALEU production milestones, and supply incidents (5B cylinder availability or TENEX delivery delays), all of which can materially move the stock. The July–September 2025 convertibility window for the $402.5M convertible notes and past ATM issuances increase potential share supply/dilution dynamics that traders should watch when interpreting insider sales. Given the nuclear/government contracting context, insiders are likely subject to strict blackout periods and may use Rule 10b5‑1 plans; any trades timed near public milestone disclosures or equity raises warrant extra scrutiny for informational asymmetry.